References
- Åberg M., Nilsson I. M. Fibrinolytic activity of the vein wall after surgery. Br J Surg 1978; 65: 259–262
- Bagge L., Saldeen T. The primary fibrinolysis inhibitor and trauma. Thromb Res 1978; 13: 1131–1136
- Bagge L. Studies on posttraumatic fibrinolysis inhibition with special reference to the primary fibrinolysis inhibitor (α2-antiplasmin). Acta Universitatis, Upsaliensis 1979, No. 342, Dissertation
- Berg W., Korsan-Bengtsen K., Ygge J. Plasminogen assay by means of the lysis time method. Thromb Diath Haemorrh 1965; 14: 127–144
- Christensen U. Allosteric effects of some antifibrinolytic amino acids on the catalytic activity of human plasmin. Biochim Biophys Acta 1978; 526: 194–201
- Collen D., Billiau A., Edy J., DeSomer P. Identification of the human plasma protein which inhibits fibrinolysis associated with malignant cells. Biochim Biophys Acta 1977; 499: 194–201
- Gallimore M. J., Shaw J. T.B. Some aspects of fibrin clot lysis and its inhibition by human serum. Thromb Diath Haemorrh 1967; 16: 101–113
- Highsmith R. F. Evidence that α2-antiplasmin is the primary physiological inhibitor of plasmin. The Physiological Inhibitors of Coagulation and Fibrinolysis, D. Collen, B. Wiman, M. Verstraete, 103–113
- Mann R. Standardization of physiological variables of the fibrinolytic system in drug and other controlled studies. Progress in Chemical Fibrinolysis and Thrombolysis 1979; 4: 143–148
- Merrills R. J., Shaw J. T.B. Kinetics of fibrin clot lysis. Biochem J 1968; 106: 101–105
- Paraskevas M., Nilsson I. M., Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand J Clin Lab Invest 1962; 14: 138–144
- Thorsen S. Influence of fibrin on the effect of 6-aminohexanoic acid on fibrinolysis caused by tissue plasminogen activator or urokinase. Progress in Chemical Fibrinolysis and Thrombolysis 1977; 3: 269–283
- Wallin R., Bagge L., Saldeen T. Viewpoints on the determination of fibrinolysis inhibition activity in blood. Forens Sci 1977; 10: 154–156